US8523123052 - Common Stock
STAAR SURGICAL CO
NASDAQ:STAA (5/9/2024, 7:20:06 PM)
After market: 42.86 0 (0%)42.86
+1.84 (+4.49%)
STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company is headquartered in Lake Forest, California and currently employs 882 full-time employees. The company is a manufacturer of lenses used worldwide in corrective or refractive surgery. The company sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. Its manufacturing facility in Monrovia, California, makes the Visian implantable Collamer lens product family, including the EVO Visian ICL, preloaded silicone cataract intraocular lenses and injector systems. Its manufacturing facility in Brugg, Switzerland, operates an administrative, distribution and operational through its subsidiary, STAAR Surgical AG. The company operates administrative and distribution facilities in Japan through its subsidiary, STAAR Japan Inc.
STAAR SURGICAL CO
25651 Atlantic Ocean Drive
Lake Forest CALIFORNIA 92630
P: 16263037902
CEO: Caren Mason
Employees: 882
Website: https://www.staar.com/
STAA stock results show that Staar Surgical missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Staar Surgical (NASDAQ:STAA) just reported results for the first quarter of 202...
Here you can normally see the latest stock twits on STAA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: